Krilogy Financial’s Harte-Hanks HHS Stock Holding History

Krilogy Financial’s Portfolio HHS Stock Details HHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$329K	Buy	152,379 +34,204	+29%	+$89.4K	0.01%	790
2026 Q1	$339K	Buy	118,175 +26,175	+28%	+$74.3K	0.01%	693
2025 Q4	$289K	Hold	92,000	–	–	0.01%	739
2025 Q3	$255K	Sell	92,000 -20,000	-18%	-$72.2K	0.01%	742
2025 Q2	$446K	Sell	112,000 -20,000	-15%	-$89.6K	0.03%	224
2025 Q1	$634K	Sell	132,000 -30,000	-19%	-$153K	0.04%	195
2024 Q4	$834K	Buy	162,000 +14,000	+9%	+$90.5K	0.06%	177
2024 Q3	$1.1M	Buy	148,000 +10,320	+7%	+$80.9K	0.08%	160
2024 Q2	$1.12M	Buy	137,680 +50,180	+57%	+$366K	0.08%	155
2024 Q1	$655K	Sell	87,500 -4,000	-4%	-$30.4K	0.05%	185
2023 Q4	$621K	Hold	91,500	–	–	0.05%	178
2023 Q3	$596K	Hold	91,500	–	–	0.05%	173
2023 Q2	$501K	Hold	91,500	–	–	0.05%	180
2023 Q1	$861K	Buy	91,500 +29,000	+46%	+$320K	0.07%	197
2022 Q4	$731K	Buy	+62,500	New	+$692K	0.07%	200

Other funds holding HHS

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

WCM

Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Raffles Associates New York $117M AUM 22.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Krilogy Financial's HHS Position: Q2 2026 in Review

Krilogy Financial increased its Harte-Hanks (HHS) stake by 29% in Q2 2026, buying an estimated $89.4K and bringing the position to 152,379 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #790.

Krilogy Financial first reported a position in HHS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.12M in Q2 2024. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.

Krilogy Financial held 152,379 shares of Harte-Hanks worth $329K as of Q2 2026.
Krilogy Financial bought 34,204 Harte-Hanks shares in Q2 2026, an estimated $89.4K.
Harte-Hanks made up 0.01% of Krilogy Financial's portfolio in Q2 2026, its #790 holding.
Krilogy Financial first reported a position in Harte-Hanks in Q4 2022 and has held it in 15 quarters since.
Krilogy Financial's Harte-Hanks position peaked at $1.12M in Q2 2024.
22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.